PRAXIS PRECISION MEDICINES I's ticker is PRAX and the CUSIP is 74006W108. A total of 69 filers reported holding PRAXIS PRECISION MEDICINES I in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,802,526 | +48.7% | 1,054,109 | 0.0% | 0.01% | +60.0% |
| Q2 2023 | $1,212,225 | +42.0% | 1,054,109 | 0.0% | 0.01% | +66.7% |
| Q1 2023 | $853,828 | -92.7% | 1,054,109 | -78.5% | 0.00% | -93.2% |
| Q4 2022 | $11,647,979 | +104742.3% | 4,894,109 | 0.0% | 0.04% | +7.3% |
| Q3 2022 | $11,110 | -99.9% | 4,894,109 | 0.0% | 0.04% | +2.5% |
| Q2 2022 | $11,991,000 | -76.0% | 4,894,109 | 0.0% | 0.04% | -68.5% |
| Q1 2022 | $49,969,000 | -48.2% | 4,894,109 | 0.0% | 0.13% | -47.5% |
| Q4 2021 | $96,414,000 | -2.4% | 4,894,109 | -8.4% | 0.24% | +10.0% |
| Q3 2021 | $98,749,000 | -6.9% | 5,340,655 | -7.9% | 0.22% | -7.9% |
| Q2 2021 | $106,051,000 | -61.8% | 5,801,487 | -31.8% | 0.24% | -56.8% |
| Q1 2021 | $277,617,000 | -40.6% | 8,501,487 | 0.0% | 0.55% | -66.4% |
| Q4 2020 | $467,752,000 | – | 8,501,487 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,469,665 | $3,497,803 | 4.70% |
| Ally Bridge Group (NY) LLC | 630,584 | $1,500,790 | 1.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,855,989 | $6,797,254 | 1.35% |
| 72 Investment Holdings, LLC | 988,995 | $2,353,808 | 1.08% |
| MPM BioImpact LLC | 610,000 | $1,451,800 | 0.38% |
| Octagon Capital Advisors LP | 800,000 | $1,904,000 | 0.30% |
| PFM Health Sciences, LP | 2,777,467 | $6,610,371 | 0.24% |
| HARVARD MANAGEMENT CO INC | 778,517 | $1,852,870 | 0.23% |
| Eventide Asset Management | 3,518,062 | $8,372,988 | 0.16% |
| Artal Group S.A. | 1,200,000 | $2,856 | 0.16% |